ETC-159
CAS: 1638250-96-0
Ref. 3D-NQC25096
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Product Information
ETC-159 is a monoclonal antibody that binds to and inhibits the function of β-catenin. It is an orally administered drug that has been shown to be effective for the treatment of solid tumours, such as colorectal cancer. ETC-159 blocks the cell signaling pathways mediated by β-catenin, which may lead to tumor suppression. This drug also has the ability to inhibit TNF-α and suppressor genes in cancer cells, which are involved in tumor growth. The chemical structure of this molecule includes a pan-PI3K inhibitor with a potential application in inhibiting cancers that are not responsive to conventional therapy.
Chemical properties
Technical inquiry about: 3D-NQC25096 ETC-159
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.